Hoyek Sandra, Lin Lisa Y, Kozek Lindsay Klofas, Gonzalez Efren, Rajabi Farrah, Patel Nimesh A
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Proc (Bayl Univ Med Cent). 2022 May 5;35(4):562-564. doi: 10.1080/08998280.2022.2071075. eCollection 2022.
Best vitelliform macular dystrophy (BVMD) is a slowly progressive macular disease caused by a pathogenic variant of the Bestrophin () gene. Examination coupled with multimodal imaging and genetic testing are used to guide diagnosis and treatment. A 12-year-old girl was examined for decreased vision in the left eye and showed bilateral "egg-yolk"-like macular lesions with choroidal neovascularization (CNV) in the left eye. Six months later, she experienced decreased vision with appearance of CNV on optical coherence tomography angiography in the right eye. Injections of anti-vascular endothelial growth factor helped restore vision from 20/125 to 20/20 in the right eye with stabilization of her left eye (vision 20/40). Genetic testing revealed c.851A > G (p.Tyr284Cys), a heterozygous variant of the gene. The same variant was found in her father, who was initially misdiagnosed with toxoplasmosis due to a peripheral retinal lesion in the left eye. This is the first report of bilateral consecutive CNV secondary to BVMD. Additionally, it highlights the likely pathogenic role of a novel variant of the gene.
最佳卵黄样黄斑营养不良(BVMD)是一种由Bestrophin()基因的致病变异引起的缓慢进展性黄斑疾病。结合多模态成像和基因检测的检查用于指导诊断和治疗。一名12岁女孩因左眼视力下降接受检查,结果显示双眼有“蛋黄”样黄斑病变,左眼伴有脉络膜新生血管(CNV)。六个月后,她右眼视力下降,光学相干断层扫描血管造影显示右眼出现CNV。注射抗血管内皮生长因子使右眼视力从20/125恢复到20/20,左眼视力稳定在20/40。基因检测发现基因的一个杂合变异c.851A > G(p.Tyr284Cys)。在她父亲身上也发现了相同的变异,其父亲最初因左眼周边视网膜病变被误诊为弓形虫病。这是首例继发于BVMD的双侧连续性CNV报告。此外,它突出了基因一种新变异可能的致病作用。